Open access
Aug 2026
Long-Term Outcomes of Expectant Management Versus Early Ibuprofen for Patent Ductus Arteriosus: 24-Month Follow-Up of the BeNeDuctus Trial.
OBJECTIVE To assess survival and neurodevelopmental outcome at 24 months' corrected age (CA) for participants in the BeNeDuctus trial, comparing expectant management with early ibuprofen treatment in extremely preterm infants. STUDY DESIGN In this international, multicenter trial, extremely preterm infants (<28 weeks...
W. Apers, T. Hundscheid, E. Kooi et al.
· Jornal de Pediatria · 0 citations